Strattera 80 mg/1 (Atomoxetine hydrochloride CAPSULE) 80 mg/1

Strattera 80 mg capsules are a non-stimulant medication used for ADHD management. This oral capsule, manufactured by Eli Lilly, is designed to support focus and impulse control.

Strength

80 mg/1

Pack Size

30 CAPSULE in 1 BOTTLE (0002-3250-30)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Strattera 80 mg capsules are primarily used for the management of attention deficit hyperactivity disorder (ADHD). This medication is often prescribed to improve focus, impulse control, and other symptoms associated with ADHD. Strattera is a non-stimulant option, making it suitable for individuals who may not tolerate stimulant medications. It works by affecting certain chemicals in the brain to help manage ADHD symptoms effectively.

Side Effects

Common effects of Strattera 80 mg capsules may include dry mouth, decreased appetite, nausea, and stomach pain. Some users may experience dizziness, fatigue, or mood changes. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

Strattera 80 mg capsules should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain heart conditions, glaucoma, or a history of substance abuse. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

Strattera 80 mg capsules can interact with various substances, including other medications, alcohol, and certain foods. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Strattera may interact with CYP2D6 inhibitors, which can affect how the body processes the medication. Always consult a healthcare provider for personalized advice.

Frequently Asked Questions

Strattera is primarily used for the management of attention deficit hyperactivity disorder (ADHD).

Strattera 80 mg capsules are typically taken orally, with or without food, as directed by a healthcare provider.

Common side effects may include dry mouth, decreased appetite, nausea, and stomach pain.

Strattera can interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Strattera may not be suitable for individuals with certain heart conditions, glaucoma, or a history of substance abuse.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.